Genelux Corp’s filing revealed that its General Counsel Ryder Sean unloaded Company’s shares for reported $13067.0 on May 12 ’25. In the deal valued at $2.92 per share,4,475 shares were sold. As a result of this transaction, Ryder Sean now holds 47,621 shares worth roughly $0.15 million.
Then, Zindrick Thomas sold 10,764 shares, generating $31,431 in total proceeds. Upon selling the shares at $2.92, the President and CEO now owns 191,447 shares.
Before that, Yu Yong sold 5,579 shares. Genelux Corp shares valued at $16,291 were divested by the VP, Clinical Trial Operations at a price of $2.92 per share. As a result of the transaction, Yu Yong now holds 47,640 shares, worth roughly $0.15 million.
Guggenheim initiated its Genelux Corp [GNLX] rating to a Buy in a research note published on October 29, 2024; the price target was $8. A number of analysts have revised their coverage, including ROTH MKM’s analysts, who began to cover the stock in late August with a ‘”a Buy”‘ rating. H.C. Wainwright began covering GNLX with “Buy” recommendation on November 27, 2023. Maxim Group started covering the stock on September 12, 2023. It rated GNLX as “a Buy”.
Price Performance Review of GNLX
On Tuesday, Genelux Corp [NASDAQ:GNLX] saw its stock fall -8.88% to $3.08. Over the last five days, the stock has lost -11.49%. Genelux Corp shares have risen nearly 20.78% since the year began. Nevertheless, the stocks have risen 30.51% over the past one year. While a 52-week high of $5.89 was reached on 02/12/25, a 52-week low of $1.60 was recorded on 04/09/25.
Levels Of Support And Resistance For GNLX Stock
The 24-hour chart illustrates a support level at 2.94, which if violated will result in even more drops to 2.79. On the upside, there is a resistance level at 3.30. A further resistance level may holdings at 3.52.
How much short interest is there in Genelux Corp?
A steep rise in short interest was recorded in Genelux Corp stocks on 2025-06-13, dropping by -0.2 million shares to a total of 2.09 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 2.28 million shares. There was a decline of -9.46%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on February 15, 2023 when The Benchmark Company began covering the stock and recommended ‘”a Speculative buy”‘ rating along with a $10 price target.
